Drager JM-103 Transcutaneous For Sale

Drager JM-103 Transcutaneous Bilirubinometer

The Drager JM-103 Transcutaneous Bilirubinometer is a reliable, non-invasive device designed for fast and accurate screening of neonatal jaundice. Widely trusted in hospitals, maternity wards, and neonatal intensive care units (NICU), the JM-103 enables clinicians to measure bilirubin levels through the skin without the need for blood sampling, reducing discomfort and stress for newborns.

Utilizing advanced optical technology, the JM-103 measures the yellowness of subcutaneous tissue by analyzing reflected light, delivering immediate and clinically reliable bilirubin estimates. Its high correlation with serum bilirubin values makes it an effective tool for early detection and monitoring of hyperbilirubinemia in newborns.

The device features an ergonomic, handheld design with intuitive one-button operation, allowing healthcare professionals to perform quick measurements at the bedside. Results are displayed instantly on a clear digital screen, supporting rapid clinical decision-making and efficient workflow in busy neonatal environments.

Designed for durability and ease of maintenance, the Drager JM-103 is suitable for repeated daily use and supports consistent screening programs. By minimizing invasive blood draws, it helps improve patient comfort, reduce infection risk, and optimize neonatal care outcomes.

Key Features

• Non-Invasive Bilirubin Measurement – Measures bilirubin levels through the skin without blood sampling.

• Fast and Accurate Results – Provides immediate readings with high correlation to serum bilirubin values.

• Advanced Optical Technology – Uses multi-wavelength light analysis for reliable transcutaneous measurements.

• Handheld and Ergonomic Design – Compact, lightweight form for comfortable one-handed operation.

• One-Button Operation – Simple and intuitive use, ideal for busy neonatal care environments.

• Clear Digital Display – Easy-to-read screen for quick interpretation of results.

• Suitable for Newborn Screening – Designed specifically for neonatal and infant jaundice assessment.

• Reduces Blood Sampling – Minimizes the need for invasive blood tests, improving patient comfort.

• Durable Clinical Design – Built for frequent daily use in hospitals and NICUs.

• Proven Clinical Performance – Widely used and trusted worldwide in neonatal care settings.

Key Benefits – Drager JM-103

• Non-Invasive Patient Comfort – Eliminates the need for blood draws, reducing pain and stress for newborns.

• Early Detection of Jaundice – Enables fast screening and monitoring of neonatal hyperbilirubinemia.

• Immediate Clinical Decisions – Instant results support timely diagnosis and treatment planning.

• Improved Workflow Efficiency – Quick, bedside measurements save time for clinical staff.

• Reduced Infection Risk – Minimizes invasive procedures, lowering the risk of infection.

• Cost-Effective Screening – Reduces laboratory testing costs by limiting unnecessary blood tests.

• User-Friendly Operation – Simple one-button design makes it easy for staff to use with minimal training.

• Portable and Lightweight – Ideal for use in maternity wards, NICUs, and neonatal clinics.

• Reliable and Consistent Readings – High accuracy and repeatability for ongoing patient monitoring.

• Trusted Clinical Tool – Proven performance in hospitals worldwide for neonatal jaundice management.

Technical Specifications

• Device Type: Transcutaneous bilirubinometer

• Measurement Method: Multi-wavelength optical reflectance technology

• Measurement Range: Typically 0–25 mg/dL (may vary by calibration/region standards)

• Display: Clear digital LCD screen

• Operation: One-button measurement

• Measurement Site: Forehead or sternum (standard testing sites)

• Result Time: Instantaneous (measurement completed within seconds)

• Accuracy: High correlation with serum bilirubin (manufacturer-validated performance)

• Calibration: Factory calibrated; optional periodic calibration per service guidelines

• Patient Population: Neonates and infants (all gestational ages)

• Power Supply: Rechargeable battery with AC charging

• Battery Life: Supports multiple measurements per charge (typical clinical use)

• Design: Handheld, ergonomic clinical form factor

• Weight: Lightweight for portable use (approx. 200–400 g)

• Durability: Designed for clinical workload and repeated daily use

• Compliance: Meets applicable medical device safety and performance standards

• Intended Use: Screening and monitoring of neonatal jaundice